{"schema_version":"1","generated_at":"2026-11-03T07:13:51.697Z","data_as_of":null,"url":"https://www.findmykol.com/kol/coral-omene","json_url":"https://www.findmykol.com/kol/coral-omene/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"coral-omene","name":"Coral Omene","credential":"MD, PhD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Rutgers","institution_url":"https://www.findmykol.com/institution/rutgers","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1861688988","orcid":"0000-0001-7824-1478","openalex":"A5008527277"},"summary":"Coral Omene is an Oncology physician affiliated with Rutgers. OpenAlex indexes 118 publications with 3,059 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":118,"cited_by_count":3059,"h_index":17,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06518837","title":"Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Rutgers, The State University of New Jersey","source_url":"https://clinicaltrials.gov/study/NCT06518837","trial_url":"https://www.findmykol.com/trial/NCT06518837"},{"nct":"NCT05736367","title":"Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"Rutgers, The State University of New Jersey","source_url":"https://clinicaltrials.gov/study/NCT05736367","trial_url":"https://www.findmykol.com/trial/NCT05736367"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":863.25,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861688988"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":67.5,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861688988"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":2740,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861688988"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1861688988","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":94.4,"classes_total":3,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":58.9,"drugs":[{"name":"Letrozole","share_pct":81.6},{"name":"Exemestane","share_pct":10.3},{"name":"Anastrozole","share_pct":8.1}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":18.2,"drugs":[{"name":"Verzenio","share_pct":50},{"name":"Ibrance","share_pct":50}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":5.6,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":5.6,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":1994,"last":2016},"rows_total":10,"shown":3,"withheld":7,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08CA172722","title":"Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)","fiscal_year":2016,"amount_usd":"172260","organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K08CA172722"},{"project":"K08CA172722","title":"Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)","fiscal_year":2015,"amount_usd":"172260","organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K08CA172722"},{"project":"K08CA172722","title":"Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)","fiscal_year":2014,"amount_usd":"155034","organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K08CA172722"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Social vulnerability and clinical trial enrollment: the next frontier of health equity","year":2025,"journal":"JNCI Journal of the National Cancer Institute","source_url":"https://doi.org/10.1093/jnci/djaf355","status":"verified"},{"title":"Abstract P2-08-25: FITWISE: Feasibility study of tirzepatide for weight loss intervention in early stage hormone receptor positive/HER2 negative breast cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-p2-08-25","status":"verified"},{"title":"Associations between experiences of discrimination and quality of life in Black breast cancer survivors","year":2025,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.35836","status":"verified"},{"title":"A Society-to-Cells approach to evaluating multilevel and interrelated drivers of breast cancer disparities in Black women","year":2025,"journal":"npj Breast Cancer","source_url":"https://doi.org/10.1038/s41523-025-00812-0","status":"verified"},{"title":"Reproducibility of Plasma Metabolome over 1 Year in a Population-Based Cohort of Black Breast Cancer Survivors","year":2025,"journal":"Cancer Epidemiology Biomarkers & Prevention","source_url":"https://doi.org/10.1158/1055-9965.epi-24-1646","status":"verified"}],"source":"works"},"contact":{"address_1":"550 1ST AVE BLDG CD","address_2":"ONCOLOGY DEPT","city":"New York","state":"NY","zip":"100166402","phone":"212-263-6485","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1861688988","source":"identity"},"similar":[{"name":"Reynold Panettieri","slug":"reynold-panettieri","institution":"Rutgers","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/reynold-panettieri","json_url":"https://www.findmykol.com/kol/reynold-panettieri/profile.json"},{"name":"Manreet Kanwar","slug":"manreet-kanwar","institution":"Rutgers","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/manreet-kanwar","json_url":"https://www.findmykol.com/kol/manreet-kanwar/profile.json"},{"name":"Jacob Sage","slug":"jacob-sage","institution":"Rutgers","specialty":"Neurology","url":"https://www.findmykol.com/kol/jacob-sage","json_url":"https://www.findmykol.com/kol/jacob-sage/profile.json"},{"name":"Brenda Kurnik","slug":"brenda-kurnik","institution":"Rutgers","specialty":"Nephrology","url":"https://www.findmykol.com/kol/brenda-kurnik","json_url":"https://www.findmykol.com/kol/brenda-kurnik/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"funding":7,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-05-03","provider_certified":"2024-05-03","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}